Atlas Legacy Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$567K Buy
4,578
+1,084
+31% +$127K 0.08% 133
2026
Q1
$420K Sell
3,494
-740
-17% -$85.4K 0.08% 139
2025
Q4
$450K Buy
4,234
+639
+18% +$60K 0.08% 138
2025
Q3
$302K Buy
3,595
+916
+34% +$75.4K 0.06% 168
2025
Q2
$212K Buy
+2,679
New +$213K 0.05% 172
2025
Q1
Sell
-2,504
Closed -$249K 182
2024
Q4
$249K Buy
+2,504
New +$258K 0.06% 157

Other funds holding MRK

Atlas Legacy Advisors's MRK Position: Q2 2026 in Review

Atlas Legacy Advisors increased its Merck (MRK) stake by 31% in Q2 2026, buying an estimated $127K and bringing the position to 4,578 shares worth $567K. The position accounts for 0.08% of the portfolio, ranked #133.

Atlas Legacy Advisors first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 1,786 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Atlas Legacy Advisors held 4,578 shares of Merck worth $567K as of Q2 2026.
  • Atlas Legacy Advisors bought 1,084 Merck shares in Q2 2026, an estimated $127K.
  • Merck made up 0.08% of Atlas Legacy Advisors's portfolio in Q2 2026, its #133 holding.
  • Atlas Legacy Advisors first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 1,786 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Atlas Legacy Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.